{"id":"https://openalex.org/W4362610044","doi":"https://doi.org/10.1158/1535-7163.22504801","title":"Supplementary Figures 1-9 from JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non\u2013small Cell Lung Cancers","display_name":"Supplementary Figures 1-9 from JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non\u2013small Cell Lung Cancers","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362610044","doi":"https://doi.org/10.1158/1535-7163.22504801"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22504801","doi":"https://doi.org/10.1158/1535-7163.22504801","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22504801","pdf_url":"https://aacr.figshare.com/ndownloader/files/39964642","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/ndownloader/files/39964642","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030967817","display_name":"Sean P. Pitroda","orcid":"https://orcid.org/0000-0003-3056-7991","observed_orcids":["https://orcid.org/0000-0003-3056-7991"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean P. Pitroda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026355446","display_name":"Melinda E. Stack","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melinda E. Stack","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069300226","display_name":"Gene-Fu Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gene-Fu Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018404172","display_name":"Sui-Sui Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sui-Sui Song","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037219238","display_name":"Lucy L Chen","orcid":"https://orcid.org/0000-0002-9956-8194","observed_orcids":["https://orcid.org/0000-0002-9956-8194"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucy Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100321337","display_name":"Hua Liang","orcid":"https://orcid.org/0000-0003-3170-6922","observed_orcids":["https://orcid.org/0000-0003-3170-6922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hua Liang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005934274","display_name":"Akash D. Parekh","orcid":"https://orcid.org/0000-0003-1659-8337","observed_orcids":["https://orcid.org/0000-0003-1659-8337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akash D. Parekh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004564183","display_name":"Xiaona Huang","orcid":"https://orcid.org/0000-0002-9983-5723","observed_orcids":["https://orcid.org/0000-0002-9983-5723"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaona Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Paul Roach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Roach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079608944","display_name":"Mitchell C. Posner","orcid":"https://orcid.org/0009-0004-6495-1961","observed_orcids":["https://orcid.org/0009-0004-6495-1961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitchell C. Posner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054855052","display_name":"Ralph R. Weichselbaum","orcid":"https://orcid.org/0000-0002-5643-8939","observed_orcids":["https://orcid.org/0000-0002-5643-8939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ralph R. Weichselbaum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5033268614","display_name":"Nikolai N. Khodarev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikolai N. Khodarev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7178000211715698,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7178000211715698,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.19629999995231628,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jak2-inhibitors","display_name":"JAK2 inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.953000009059906},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9729999899864197},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6970000267028809},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.6890000104904175},{"id":"https://openalex.org/keywords/clonogenic-survival","display_name":"clonogenic survival","score":0.8209999799728394},{"id":"https://openalex.org/keywords/radiosensitivity","display_name":"radiosensitivity","score":0.6439999938011169},{"id":"https://openalex.org/keywords/cisplatin-based-chemotherapy","display_name":"cisplatin-based chemotherapy","score":0.7149999737739563},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.8180000185966492},{"id":"https://openalex.org/keywords/survival-prediction","display_name":"survival prediction","score":0.5490000247955322}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5732942223548889},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5479429364204407},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.509606122970581},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49979066848754883},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.4926484227180481},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.49098852276802063},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45550537109375},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.427814781665802},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3913477957248688},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3048745393753052},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23675674200057983},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.12463054060935974},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09961971640586853}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22504801","doi":"https://doi.org/10.1158/1535-7163.22504801","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22504801","pdf_url":"https://aacr.figshare.com/ndownloader/files/39964642","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22504801.v1","doi":"https://doi.org/10.1158/1535-7163.22504801.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22504801.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22504801","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_1-9_from_JAK2_Inhibitor_SAR302503_Abrogates_PD-L1_Expression_and_Targets_Therapy-Resistant_Non_small_Cell_Lung_Cancers/22504801","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22504801","doi":"https://doi.org/10.1158/1535-7163.22504801","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22504801","pdf_url":"https://aacr.figshare.com/ndownloader/files/39964642","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8565000295639038}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362610044.pdf","grobid_xml":"https://content.openalex.org/works/W4362610044.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392723029","https://openalex.org/W2793883178","https://openalex.org/W3178945051","https://openalex.org/W4392678728","https://openalex.org/W1986099901","https://openalex.org/W2316172834","https://openalex.org/W2889998214","https://openalex.org/W6921584525","https://openalex.org/W6964228683","https://openalex.org/W2741838836"],"abstract_inverted_index":{"Supplemental":[0,19,42,53,65,76,86,95],"Figure":[1,20,32,43,54,66,77,87,96,111],"S1.":[2],"Comparison":[3],"of":[4,8,36,70,80,103],"clonogenic":[5],"survival":[6,91],"fractions":[7],"various":[9],"cancer":[10],"cell":[11,29,51],"lines":[12],"after":[13],"treatment":[14,25],"with":[15],"SAR302503":[16],"and":[17,58,112],"Ruxolitinib.":[18],"S2.":[21],"KRAS":[22],"mutation":[23],"by":[24,73],"sensitivities":[26],"in":[27,47,62,83,92,107],"NSCLC":[28,50],"lines.":[30,52],"Supplementary":[31,110],"S3.":[33],"The":[34],"response":[35],"NCIH1944":[37],"xenografts":[38],"to":[39],"ionizing":[40],"radiation.":[41],"S4.":[44],"Top-ranked":[45],"pathways":[46],"SAR":[48,71],"sensitive":[49],"S5.":[55],"Cancer":[56],"growth":[57],"proliferation":[59],"gene":[60],"network":[61],"SAR-sensitive":[63],"NSCLC.":[64,94,109],"S6.":[67],"ROC":[68],"analysis":[69],"sensitivity":[72],"TSP-IRDS":[74,81,89,98],"scores.":[75],"S7.":[78],"Distribution":[79],"scores":[82,99],"clinical":[84,93,108],"NSCLCs.":[85],"S8.":[88],"predicts":[90],"S9.":[97],"predict":[100],"the":[101],"benefit":[102],"adjuvant":[104],"cisplatin-based":[105],"chemotherapy":[106],"Table":[113],"Legends":[114]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}